William A. Haseltine, Contributor

Author's posts

New Insights Into Lung Damage And Repair Relevant To Covid-19

A new study shines light onto the intricate and aberrant process by which hAEC2 cells turn into basal cells in response to severe alveolar injuries, a transformation that changes the architecture of the lungs and can lead to further damage as well as i…

Breaching The Barrier That Protects Children From Serious Covid-19-Related Disease

With data suggesting children may be less protected against Omicron than previous SARS-CoV-2 variants, we need clarity on what drives risk and protection in younger populations. Why the virus largely spares children was anyone’s guess, until now.

Difficulties Of Single Monoclonal Antibody Treatment Of SARS-CoV-2: The Sotrovimab Experience In Australia

Rockett et al. demonstrate that resistance to sotrovimab as a monotherapy rises rapidly in treated patients.

3D Printed Skin? Potential New Treatment For Chronic Wounds

In a paper published in APL Bioengineering, Richard Moakes et al. describe the process by which they managed to 3D print a functional skin equivalent that can be inserted into wounds to speed up recovery.

Hook, Line, And Sinker: Do Rockfish Hold The Secret To Living Longer?

Because aging is a significant risk factor for several human diseases, such as cancer, diabetes and neurological disorders, understanding the genetic adaptations that promote longevity in rockfish species provides insight into human aging and disease.

New Evidence Of Immune Suppression By SARS-CoV-2

We now have evidence, in the form of three new studies, that shows exactly why we call SARS-CoV-2 the champion of immune suppression.

Pfizer’s New Antiviral Drug Could Transform The Pandemic, But Challenges Still Lie Ahead

The pill could reduce the burden on our overwhelmed hospitals during this current surge of Omicron-driven cases that has already exceeded the peak of the recent Delta wave.

Omicron Evades Most But Fortunately Not All Monoclonal Antibodies

At present, there are at least five well-characterized antibodies that retain potency against most variants of SARS-CoV-2 including Omicron.

Another Variant Emerges From An Immunocompromised Patient

Here we examine one such case of a 72-year-old patient who was infected continuously for two months, as detailed by Truffot et al.

Non-Spike Proteins Contribute To Transmission And Virulence Of Sars-Cov-2

A new report, led by researchers with the Oak Ridge National Laboratory, prompts us to shift our focus towards the entirety of the viral genome, rather than just the S protein.